A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents

NCT02517892 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Oncogen-driven Cancer

Interventions

PROCEDURE: Biopsy

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris